Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Anaprazole with High Fat Food in Healthy Chinese Subjects
NCT04463173Phase 1Completed
- Sponsor
- Sihuan Pharmaceutical
- Start
- Jun 2015
- Primary completion
- Jul 2015
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of Anaprazole in duodenal ulcer and gastroesophageal reflux disease (GERD) (2 arms), sponsored by Sihuan Pharmaceutical. Primary endpoints: Area Under the Curve at 24 hours, Maximum Plasma Concentration at 24 hours and 1 more. Started Jun 2015; status: completed.
02
Drugs
Anaprazole
03
Conditions
duodenal ulcergastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT04463173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04463173.